189
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada

, , , , , & show all
Pages 2003-2013 | Published online: 03 Sep 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Lili Jiang, Tetyana Kendzerska, Shawn D. Aaron, Therese A. Stukel, Matthew B. Stanbrook, Wan Tan, Priscila Pequeno & Andrea S. Gershon. (2022) Prescription Pathways from Initial Medication Use to Triple Therapy in Older COPD Patients: A Real-World Population Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 19:1, pages 315-323.
Read now
Dea Kejlberg Andelius, Ole Hilberg, Rikke Ibsen & Anders Løkke. (2021) National Epidemiological Case–Control Study of Pharmacological Smoking Cessation Treatment in Danish Patients with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2433-2443.
Read now
Taraneh Bahremand, Mahyar Etminan, Nardin Roshan-Moniri, Mary A De Vera, Hamid Tavakoli & Mohsen Sadatsafavi. (2021) Are COPD Prescription Patterns Aligned with Guidelines? Evidence from a Canadian Population-Based Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 751-759.
Read now
Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Gabriella Matera, Mario Cazzola & Paola Rogliani. (2020) Evaluation of fluticasone propionate/salmeterol for the treatment of COPD: a systematic review. Expert Review of Respiratory Medicine 14:6, pages 621-635.
Read now
Chloe I Bloom, Ian Douglas, Omar S Usmani & Jennifer K Quint. (2020) Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 701-710.
Read now

Articles from other publishers (9)

Subash Heraganahally, Timothy P Howarth, Siji Issac, Angus Lloyd, Shiidheshwar J Ravichandran, Asanga Abeyaratne & Bhavini Patel. (2023) Exploring the appropriateness of prescribing practice of inhaled pharmacotherapy among Aboriginal Australians in the Top End Northern Territory of Australia: a retrospective cohort study. BMJ Open Respiratory Research 10:1, pages e001508.
Crossref
Kristina D. Michaux, Rebecca K. Metcalfe, Paloma Burns, Annalijn I. Conklin, Alison M. Hoens, Daniel Smith, Laura Struik, Abdollah Safari, Don D. Sin, Mohsen Sadatsafavi, Nick Bansback, Prabjit Barn, Joan L. Bottorff, Stirling Bryan, Chris Carlsten, Mary De Vera, Andrea Gershon, Samir Gupta, Paul Gustafson, Mehrshad Mokhtaran, Jim Johnson, Phalgun Joshi, Janice Leung, Larry D. Lynd, Brian Simmers, Janet Sutherland & Dhingra Vinay. (2023) IMplementing Predictive Analytics towards efficient COPD Treatments (IMPACT): protocol for a stepped-wedge cluster randomized impact study. Diagnostic and Prognostic Research 7:1.
Crossref
Evdoxia Gogou, Chryssi Hatzoglou, Sotirios G. Zarogiannis, Dimitra Siachpazidou, Irini Gerogianni, Ourania S. Kotsiou, Charalampos Varsamas & Konstantinos I. Gourgoulianis. (2022) Are younger COPD patients adequately vaccinated for influenza and pneumococcus?. Respiratory Medicine 203, pages 106988.
Crossref
Bonnie He, Hamid Tavakoli, Mahyar Etminan, Shayan Shokoohi, Alfonso Iovieno & Sonia N. Yeung. (2022) Impact of the use of anti-glaucoma medications on the risk of herpetic keratitis recurrence. International Ophthalmology 43:5, pages 1559-1564.
Crossref
Michael Poon, Priscila Pequeno, Shawn D. Aaron, Matthew B. Stanbrook, Harvey H. Wong, Peter Cram & Andrea S. Gershon. (2022) Trends in non-receipt of recommended COPD medication. ERJ Open Research 8:2, pages 00584-2021.
Crossref
Ye Jin Lee, Chin Kook Rhee, Yong Il Hwang, Kwang Ha Yoo, So Eun Lee, Doik Lee, Yong Bum Park & Youlim Kim. (2021) Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea (CITRUS) Study. Journal of Personalized Medicine 11:12, pages 1325.
Crossref
Lili Chen & Shiping Chen. (2021) Prediction of readmission in patients with acute exacerbation of chronic obstructive pulmonary disease within one year after treatment and discharge. BMC Pulmonary Medicine 21:1.
Crossref
Liam Knox, Rachel Gemine, Sarah Rees, Sarah Bowen, Phil Groom, David Taylor, Ian Bond & Keir Lewis. (2021) Assessing the uptake, engagement, and safety of a self-management app, COPD.Pal®, for Chronic Obstructive Pulmonary Disease: a pilot study. Health and Technology 11:3, pages 557-562.
Crossref
Kate M. Johnson, Mohsen Sadatsafavi, Amin Adibi, Larry Lynd, Mark Harrison, Hamid Tavakoli, Don D. Sin & Stirling Bryan. (2020) Cost Effectiveness of Case Detection Strategies for the Early Detection of COPD. Applied Health Economics and Health Policy 19:2, pages 203-215.
Crossref